These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6971165)

  • 41. The use of H-2 mutants as models for the study of T cell activation.
    McKenzie IF; Pang T; Blanden RV
    Immunol Rev; 1977; 35():179-230. PubMed ID: 70397
    [No Abstract]   [Full Text] [Related]  

  • 42. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Xenogeneic antisera against T-lymphocyte receptors recognizing allogeneic transplantation antigens: preparation and properties.
    Nesterenko VG; Kraskina NA; Rubakova EI; Gruner S
    Cell Immunol; 1982 May; 69(2):215-26. PubMed ID: 6980719
    [No Abstract]   [Full Text] [Related]  

  • 45. Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E).
    Kimura M; van Rappard-van der Veen FM; Gleichmann E
    Clin Exp Immunol; 1986 Sep; 65(3):542-52. PubMed ID: 3490938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Both class I and class II responsive T cell subsets can separately initiate lethal graft-versus-host disease in H-2-incompatible murine radiation chimeras.
    Carmody L; Atkinson K; Cooley M; Chapman G; Biggs J; McKenzie I
    Transplant Proc; 1987 Apr; 19(2):2876-8. PubMed ID: 3105125
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice.
    Kataoka H; Ohtsuki M; Shimano K; Mochizuki S; Oshita K; Murata M; Sugahara K; Sato N; Hoshino Y; Chiba K
    Transplant Proc; 2005; 37(1):107-9. PubMed ID: 15808562
    [No Abstract]   [Full Text] [Related]  

  • 48. Importance of intrathymic mixed chimerism for maintenance of skin allograft tolerance across fully allogeneic (entire major H-2 plus multiminor histocompatibility) antigen barriers in mice.
    Eto M; Nishimura Y; Kong YY; Maeda T; Nomoto K; Kumazawa J; Nomoto K
    Transplant Proc; 1994 Apr; 26(2):841-4. PubMed ID: 8171683
    [No Abstract]   [Full Text] [Related]  

  • 49. H-2-restriction of T cells mediating lethal graft-versus-host-disease to minor histocompatibility determinants.
    Sprent J; Korngold R
    Adv Exp Med Biol; 1982; 149():531-6. PubMed ID: 6816025
    [No Abstract]   [Full Text] [Related]  

  • 50. Cell-cell interaction in graft-rejection responses: breakdown of tolerance to allo-class I H-2 antigens by helper T cells against other histocompatibility antigens simultaneously expressed on a graft.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):96-8. PubMed ID: 1825007
    [No Abstract]   [Full Text] [Related]  

  • 51. [The functional differentiation of thymocytes under exposure to soluble H-2K k antigens released by macrophages in joint culture with the thymocytes].
    Semenkova LN; Dudich EI; Dudich IV; Galaktionov VG
    Dokl Akad Nauk SSSR; 1990; 315(6):1504-6. PubMed ID: 2088702
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunosuppression and malignant lymphomas in graft-versus-host reactions.
    Solnik C; Gleichmann H; Kavanah M; Schwartz RS
    Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854
    [No Abstract]   [Full Text] [Related]  

  • 53. Specific and nonspecific T-cell-mediated suppression of antihost immune reactivity in graft-versus-host reaction.
    Bril H; Molendijk-Lok BD; Benner R
    Transplantation; 1983 Sep; 36(3):323-8. PubMed ID: 6193618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction and suppression of graft-versus-host reactivity in B6.C-H-2 mutant mice.
    Molendijk A; van Gurp RJ; van Oudenaren A; Benner R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2698-9. PubMed ID: 2978897
    [No Abstract]   [Full Text] [Related]  

  • 55. Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine.
    Mowat AM; Ferguson A
    Gastroenterology; 1982 Aug; 83(2):417-23. PubMed ID: 6979490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E; Bonavida B
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract]   [Full Text] [Related]  

  • 57. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction and avoidance of graft-versus-host reactions: a review.
    Simonsen M
    J R Soc Med; 1981 Dec; 74(12):901-3. PubMed ID: 7033532
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
    Annat J; Churaqui E; Dutartre P; Bruley-Rosset M
    Transplantation; 1996 Sep; 62(6):721-9. PubMed ID: 8824467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.